March 18, 2020 / 6:27 AM / 15 days ago

BRIEF-Vivoryon Therapeutics Announces Update On Phase 2B Alzheimer's Clinical Trial, Viviad

March 18 (Reuters) - VIVORYON THERAPEUTICS AG:

* ANNOUNCES UPDATE ON PHASE 2B ALZHEIMER’S CLINICAL TRIAL, VIVIAD

* STUDY IS SCHEDULED TO ENROLL ITS FIRST PATIENT IN Q2 2020 WITH TOPLINE RESULTS EXPECTED TOWARDS END OF 2022 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below